Pittsburgh, PA (PRWEB) December 22, 2011
Celsense, Inc., announced nowadays that it has received a Notice of Allowance for US Patent Application 10/586,015 with claim cover IT MRI compartment trailing ware, Cell Sense.
Cell Sense is a perfluorocarbon tracer pressor used to description cell ex vivo, devising them detectable in vivo after transplantation victimisation magnetic oscillation imagination (MRI). Invented by Eric Ahrens at Carnegie Mellon University, Cell Sense tin be used to non-invasively thought-image the disposal, expatriation, and continuity of cell transplanted for remedy or diagnostic aim victimisation MRI. The utilisation of Cell Sense was former reported in the diary Nature Biotechnology in 2005.
Cell Sense is currently available for utilization in preclinical investigation and man clinical trial. The former clinical utilization of Cell Sense is in amalgam with an autologous dendritic compartment vaccinum used to delicacy colorectal lymphoma; the mistrial was authorized by the US FDA in May of 2011. It is contemplated that alexic enlisting will commence in early 2012.
The papers, Cellular labeling for nuclear magnetic oscillation technique, includes a woman dentition of claim cover method and composition for the usage of perfluorocarbon tracer agent to detect transplanted cell in MRI and nuclear magnetic oscillation (NMR). Ropes and Gray LLP acted as counselor to Carnegie Mellon University and Celsense, Inc., in the action of the document.
“We are delighted to add this patent to our growing intellectual property portfolio and to extend our leadership position in cellular and molecular imagination tool,” said Charlie O’Hanlon, President and CEO of Celsense.
About Celsense, Inc.
Celsense, Inc. develop and markets fiction ware that enable the non-invasive imaging of populations of cell using in vivo using MRI. Customers include starring pharmaceutic and biotechnology company and medical research centers worldwide. Celsenses mission is to be the measure for cellular imaging in human wellness.
###
Find More Nuclear Press Releases
